Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    New MRSA Superbug Emerges in Brazil

    By Global Biodefense StaffApril 24, 2014
    Micrograph of Methicillin-Resistant Staphylococcus aureus (MRSA)
    Scanning electron micrograph of methicillin-resistant Staphylococcus aureus and a dead human neutrophil. Credit: NIAID
    Share
    Facebook LinkedIn Reddit Email

    An international research team led by the University of Texas Health Science Center at Houston (UTHealth) has identified a new superbug that caused a bloodstream infection in a Brazilian patient.

    The new superbug is part of a class of highly-resistant bacteria known as methicillin-resistant Staphylococcus aureus or MRSA, which is a major cause of hospital and community-associated infections. The superbug has also acquired high levels of resistance to vancomycin, the most common and least expensive antibiotic used to treat severe MRSA infections worldwide.

    Community-Associated MRSA

    Most worrisome is that genomic analyses indicated that this novel vancomycin-resistant MRSA superbug belongs to a genetic lineage that is commonly found outside hospitals (designated community-associated MRSA), said Cesar A. Arias, M.D., Ph.D., the report’s senior author and an associate professor of medicine, microbiology and molecular genetics at the UTHealth Medical School.

    Previous research has suggested that community-associated MRSA can disseminate rapidly among people and is responsible for the majority of skin and soft tissue infections in patients of all ages. Some of these infections can become serious and even fatal.

    Since community-associated MRSA is thought to be transmitted mainly by skin contact, the new superbug may affect not only sick people or those with a weakened immune system but also healthy individuals, according to Arias. Apart from causing localized skin infections, the MRSA superbug has the ability to invade the bloodstream and may become a serious threat.

    “This is the first-ever reported bloodstream infection caused by a highly vancomycin-resistant MRSA bacteria,” Arias said. “If we lose vancomycin, it would make it very difficult and expensive to treat these infections,” he said.

    The vanA Gene Cluster

    Arias and his colleagues conducted microbiological and genetic analyses of an MRSA superbug recovered from the blood of a 35-year-old Brazilian man and identified a novel transferable genetic element (plasmid) that carries the genes necessary for vancomycin resistance (vanA gene cluster).

    “The presence and dissemination of community-associated MRSA containing vanA could become a serious public health concern,” report the authors in the paper.

    However, since this is the only documented case of this type of infection, Arias said, it is too early to tell if this specific superbug will lead to a bigger threat.

    Barbara E. Murray, M.D., report co-author and director of the Division of Infectious Diseases at the UTHealth Medical School, said, “The worst resistance possible has now appeared in the community-associated MRSA clone.”

    The report appeared in the April 17 issue of The New England Journal of Medicine: Transferable Vancomycin Resistance in Community-Associated MRSA Lineage.

    Source: University of Texas Health Science Center at Houston 

    Antimicrobials Emerging Threats MRSA
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleNovel Agent for Tamiflu-Resistant pH1N1 Influenza Virus Discovered
    Next Article NIAID Awards $5.3 Million for Influenza POC Diagnostic System

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    The Basics on the Nipah Virus Outbreak in India

    September 19, 2023

    Case Study: Fatal Avian Influenza Infection in Cat in Poland

    September 15, 2023

    Bird Flu Undergoing Changes That Could Increase Risk of Widespread Human Transmission

    September 14, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy